These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2085969)

  • 1. Mifepristone (RU 486) for cervical priming prior to surgically induced abortion in the late first trimester.
    Urquhart DR; Templeton AA
    Contraception; 1990 Aug; 42(2):191-9. PubMed ID: 2085969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
    Henshaw RC; Templeton AA
    Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion?
    Gupta JK; Johnson N
    Contraception; 1992 Nov; 46(5):489-97. PubMed ID: 1458895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study.
    Cohn M; Stewart P
    Br J Obstet Gynaecol; 1991 Aug; 98(8):778-82. PubMed ID: 1911585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
    Durlot F; Dubois C; Brunerie J; Frydman R
    Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix.
    Gupta JK; Johnson N
    Lancet; 1990 May; 335(8700):1238-40. PubMed ID: 1971320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.
    Frydman R; Fernandez H; Pons JC; Ulmann A
    Hum Reprod; 1988 Aug; 3(6):803-6. PubMed ID: 3065355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
    Thong KJ; Baird DT
    Contraception; 1992 Jul; 46(1):11-7. PubMed ID: 1424619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of RU-38486 on cervical ripening. Clinical studies.
    Lefebvre Y; Proulx L; Elie R; Poulin O; Lanza E
    Am J Obstet Gynecol; 1990 Jan; 162(1):61-5. PubMed ID: 2301519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy.
    Ngai SW; Tang OS; Lao T; Ho PC; Ma HK
    Hum Reprod; 1995 May; 10(5):1220-2. PubMed ID: 7657769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced cervical ripening with Mifepristone in first trimester abortion. A double-blind randomized biomechanical study.
    Rådestad A; Christensen NJ; Strömberg L
    Contraception; 1988 Sep; 38(3):301-12. PubMed ID: 3168450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of the cervix prior to surgical evacuation of the uterus in the late first and early second trimester of pregnancy.
    Herczeg J
    Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):307-25. PubMed ID: 2225602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical priming before first trimester aspiration abortion: a single blind study comparing gemeprost 1 mg and prostaglandin E2 10 mg pessaries.
    Mackenzie IZ; Jackson C; Mckinlay E; Millar J
    J Obstet Gynaecol (Lahore); 1990 Oct; 10(6):513-7. PubMed ID: 12284145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Gemeprost vaginal suppository for cervical priming prior to termination of first trimester pregnancy.
    Kajanoja P; Mandelin M; Mäkilä UM; Ylikorkala O; Felding C; Somell C; Olund A; Pedersen H
    Contraception; 1984 Mar; 29(3):251-60. PubMed ID: 6539662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilatation of the cervix by oral PGE2 before first-trimester termination of pregnancy.
    Somell C; Olund A; Kindahl H; Larsson B
    Acta Obstet Gynecol Scand; 1984; 63(7):625-8. PubMed ID: 6393687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of damage to the cervix by dilatation for first-trimester-induced abortion by suction aspiration.
    Molin A
    Gynecol Obstet Invest; 1993; 35(3):152-4. PubMed ID: 8505006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
    Ulmann A; Silvestre L; Chemama L; Rezvani Y; Renault M; Aguillaume CJ; Baulieu EE
    Acta Obstet Gynecol Scand; 1992 May; 71(4):278-83. PubMed ID: 1322621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
    Birgerson L; Odlind V
    Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.